403 related articles for article (PubMed ID: 23031851)
1. Serum 25(OH)D and incident type 2 diabetes: a cohort study.
Husemoen LL; Skaaby T; Thuesen BH; Jørgensen T; Fenger RV; Linneberg A
Eur J Clin Nutr; 2012 Dec; 66(12):1309-14. PubMed ID: 23031851
[TBL] [Abstract][Full Text] [Related]
2. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab).
Gagnon C; Lu ZX; Magliano DJ; Dunstan DW; Shaw JE; Zimmet PZ; Sikaris K; Ebeling PR; Daly RM
J Clin Endocrinol Metab; 2012 Jun; 97(6):1953-61. PubMed ID: 22442263
[TBL] [Abstract][Full Text] [Related]
3. Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults.
Schöttker B; Herder C; Rothenbacher D; Perna L; Müller H; Brenner H
Eur J Epidemiol; 2013 Mar; 28(3):267-75. PubMed ID: 23354985
[TBL] [Abstract][Full Text] [Related]
4. The relationship of vitamin D status to risk of cardiovascular disease and mortality.
Skaaby T
Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634511
[TBL] [Abstract][Full Text] [Related]
5. Serum 25-hydroxyvitamin D and incidence of diabetes in elderly people: the PRO.V.A. study.
Veronese N; Sergi G; De Rui M; Bolzetta F; Toffanello ED; Zambon S; Corti MC; Sartori L; Musacchio E; Baggio G; Crepaldi G; Perissinotto E; Manzato E
J Clin Endocrinol Metab; 2014 Jul; 99(7):2351-8. PubMed ID: 24731010
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
7. 25-Hydroxyvitamin D and the risk of incident diabetes in Hong Kong Chinese.
Leung RY; Cheung BM; Tan KC; Kung AW; Cheung CL
Public Health Nutr; 2020 May; 23(7):1201-1207. PubMed ID: 31169100
[TBL] [Abstract][Full Text] [Related]
8. A combination of low serum concentrations of vitamins K1 and D is associated with increased risk of hip fractures in elderly Norwegians: a NOREPOS study.
Finnes TE; Lofthus CM; Meyer HE; Søgaard AJ; Tell GS; Apalset EM; Gjesdal C; Grimnes G; Schei B; Blomhoff R; Samuelsen SO; Holvik K
Osteoporos Int; 2016 Apr; 27(4):1645-1652. PubMed ID: 26630974
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the Finnish Diabetes Risk Score (FINDRISC), vitamin D levels, and insulin resistance in obese subjects.
Lima-Martínez MM; Arrau C; Jerez S; Paoli M; González-Rivas JP; Nieto-Martínez R; Iacobellis G
Prim Care Diabetes; 2017 Feb; 11(1):94-100. PubMed ID: 27914905
[TBL] [Abstract][Full Text] [Related]
10. Association of serum 25-hydroxyvitamin D with type 2 diabetes and markers of insulin resistance in a general older population in Finland.
Hurskainen AR; Virtanen JK; Tuomainen TP; Nurmi T; Voutilainen S
Diabetes Metab Res Rev; 2012 Jul; 28(5):418-23. PubMed ID: 22318870
[TBL] [Abstract][Full Text] [Related]
11. Serum 25(OH)D and adipokines levels in people with abdominal obesity.
Karonova T; Belyaeva O; Jude EB; Tsiberkin A; Andreeva A; Grineva E; Pludowski P
J Steroid Biochem Mol Biol; 2018 Jan; 175():170-176. PubMed ID: 27629594
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
Ginde AA; Scragg R; Schwartz RS; Camargo CA
J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D status and its relationship with metabolic markers in persons with obesity and type 2 diabetes in the UAE: a cross-sectional study.
Sadiya A; Ahmed SM; Skaria S; Abusnana S
J Diabetes Res; 2014; 2014():869307. PubMed ID: 25371907
[TBL] [Abstract][Full Text] [Related]
14. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort.
Mousa A; Naderpoor N; de Courten MPJ; Scragg R; de Courten B
J Steroid Biochem Mol Biol; 2017 Oct; 173():258-264. PubMed ID: 28007531
[TBL] [Abstract][Full Text] [Related]
15. Association between serum 25(OH)D
Samefors M; Scragg R; Länne T; Nyström FH; Östgren CJ
Diabet Med; 2017 Mar; 34(3):372-379. PubMed ID: 27862247
[TBL] [Abstract][Full Text] [Related]
16. Serum 25-hydroxy vitamin D and the risk of low muscle mass in young and middle-aged Korean adults.
Kim Y; Chang Y; Ryu S; Cho IY; Kwon MJ; Wild SH; Byrne CD
Eur J Endocrinol; 2022 Mar; 186(4):477-487. PubMed ID: 35147511
[TBL] [Abstract][Full Text] [Related]
17. Higher serum 25(OH)D level is associated with decreased risk of impairment of glucose homeostasis: data from Southwest China.
Li D; Wei H; Xue H; Zhang J; Chen M; Gong Y; Cheng G
BMC Endocr Disord; 2018 May; 18(1):25. PubMed ID: 29739382
[TBL] [Abstract][Full Text] [Related]
18. Serum 25-Hydroxyvitamin D were associated with higher risk of both albuminuria and impaired GFR incidence: a cohort study based on CLHLS study.
Liu M; Wang J; He Y
BMC Nephrol; 2019 Jan; 20(1):20. PubMed ID: 30646860
[TBL] [Abstract][Full Text] [Related]
19. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
Schmutz EA; Zimmermann MB; Rohrmann S
Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
[TBL] [Abstract][Full Text] [Related]
20. Impact of hip circumference and height on incident diabetes: results from 6-year follow-up in the Tehran Lipid and Glucose Study.
Bozorgmanesh M; Hadaegh F; Zabetian A; Azizi F
Diabet Med; 2011 Nov; 28(11):1330-6. PubMed ID: 21627688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
